Can California Opioid Ruling Help Manufacturers In Pending Cases?
Executive Summary
Judge’s dismissal of all claims against opioid makers offers hope they can win other cases and may push forward settlements. But it is ‘bookend’ by the Oklahoma case that reached a dramatically divergent conclusion, so while significant, it is only a single data point, Stanford law professor says.
You may also be interested in...
Selling Opioids Is Not A Public Nuisance For Three Reasons, Oklahoma State Appeals Court Rules
Overturning a $465m verdict against J&J, Oklahoma Supreme Court rejects claim opioid sales violated a public right. It says a manufacturer does not have control of its product once it is sold and cannot be held perpetually liable for its products.
Vaccine Technologies: US FDA Isn’t Afraid Of Needle-Free Delivery, But It Takes Time To Develop, Woodcock Says
The agency is interested in alternative formulations for COVID-19 inoculations, but pushed the traditional injection presentation because it was easier to develop quickly.
J&J, Distributors May Be Free Of Opioid Litigation If Enough States Sign On To $26bn Settlement
NY AG has ‘no comment’ on whether criminal charges will be pursued against company executives; NC AG predicts ‘north of 40 states’ expected to accept settlement and would then need to convince municipalities to come on board. States with ongoing litigation against manufacturers may opt for jury trial instead.